Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer
- PMID: 31118036
- PMCID: PMC6530145
- DOI: 10.1186/s12943-019-1028-9
Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer
Abstract
Cancer-associated chromosomal translocations are reported to generate oncogenic circular RNA (circRNA), contributing to tumorigenesis. The fusion gene SLC34A2-ROS1 (solute carrier family 34 member 2 and ROS proto-oncogene 1) plays an important role in non-small cell lung cancer (NSCLC) progression. However, whether SLC34A2-ROS1 gene can produce circRNA remains unknown. Here, we identified two novel circRNAs (F-circSR1 and F-circSR2) generated from SLC34A2-ROS1 fusion gene, while F-circSR1 has higher expression than F-circSR2. Functional studies through gain- and loss-of-function strategies showed that both F-circSRs promote cell migration in lung cancer cells, whereas they have little effect on cell proliferation. Using the minigene GFP reporter assay, we verified that the flanking complementary sequences with canonical splicing sites are essential for F-circSR biogenesis. Therefore, our findings demonstrate the oncogenic role of F-circSR in NSCLC and highlight its therapeutic potential.
Keywords: Cell migration; Circular RNA; NSCLC; SLC34A2-ROS1.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma.Oncol Rep. 2013 Oct;30(4):1675-80. doi: 10.3892/or.2013.2630. Epub 2013 Jul 19. Oncol Rep. 2013. PMID: 23877438
-
CD74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 Mutations.J Thorac Oncol. 2024 Apr;19(4):613-625. doi: 10.1016/j.jtho.2023.12.009. Epub 2023 Dec 7. J Thorac Oncol. 2024. PMID: 38070598
-
3D culture system containing gellan gum restores oncogene dependence in ROS1 rearrangements non-small cell lung cancer.Biochem Biophys Res Commun. 2018 Jun 22;501(2):527-533. doi: 10.1016/j.bbrc.2018.05.031. Epub 2018 May 10. Biochem Biophys Res Commun. 2018. PMID: 29738763
-
ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.Pharmacol Res. 2017 Jul;121:202-212. doi: 10.1016/j.phrs.2017.04.022. Epub 2017 Apr 30. Pharmacol Res. 2017. PMID: 28465216 Review.
-
[A new target in non-small cell lung cancer: ROS1 fusion gene].Zhonghua Zhong Liu Za Zhi. 2013 Jan;35(1):1-4. doi: 10.3760/cma.j.issn.0253-3766.2013.01.001. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23648291 Review. Chinese. No abstract available.
Cited by
-
Biological roles and potential clinical values of circular RNAs in gastrointestinal malignancies.Cancer Biol Med. 2021 Mar 12;18(2):437-57. doi: 10.20892/j.issn.2095-3941.2020.0348. Online ahead of print. Cancer Biol Med. 2021. PMID: 33710802 Free PMC article. Review.
-
An update on the roles of circular RNAs in osteosarcoma.Cell Prolif. 2021 Jan;54(1):e12936. doi: 10.1111/cpr.12936. Epub 2020 Oct 25. Cell Prolif. 2021. PMID: 33103338 Free PMC article. Review.
-
Uncovering the prognostic gene signatures for the improvement of risk stratification in cancers by using deep learning algorithm coupled with wavelet transform.BMC Bioinformatics. 2020 May 19;21(1):195. doi: 10.1186/s12859-020-03544-z. BMC Bioinformatics. 2020. PMID: 32429941 Free PMC article.
-
Current treatment and novel insights regarding ROS1-targeted therapy in malignant tumors.Cancer Med. 2024 Apr;13(8):e7201. doi: 10.1002/cam4.7201. Cancer Med. 2024. PMID: 38629293 Free PMC article. Review.
-
CircUCP2 promotes the tumor progression of non-small cell lung cancer through the miR-149/UCP2 pathway.Oncol Res. 2023 Sep 15;31(6):929-936. doi: 10.32604/or.2023.030611. eCollection 2023. Oncol Res. 2023. PMID: 37744277 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
